ARISTOCORT R 0.1 %
TRIAMCINOLONE ACETONIDE : 0.1 % · DIN 02194031 · BAUSCH HEALTH, CANADA INC.
Health Canada status: MARKETED
What is ARISTOCORT R?
ARISTOCORT R 0.1 % contains TRIAMCINOLONE ACETONIDE : 0.1 %. It is listed in the Health Canada Drug Product Database under DIN 02194031, held by BAUSCH HEALTH, CANADA INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as marketed, status dated 24-Nov-2020. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ARISTOCORT R used for?
Indicated for topical therapy of corticosteroid responsive acute and chronic dermatoses, where an anti-inflammatory, anti- allergenic and antipruritic activity in topical management is required. ARISTOCORT triamcinolone acetonide topical preparations have been demonstrated to be effective in the adjunctive treatment of the following dermatoses: atopic dermatitis, pruritus vulvae and ani, generalized erythorodermia, external otitis, seborrheic dermatitis, eczematized psoriasis, neurodermatitis. The concentrated 0.5 % ARISTOCORT C triamcinolone acetonide preparation has been of greatest usefulness in the initial suppression of the acute manifestations of difficult to manage dermatologic conditions.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02194031 |
|---|---|
| Brand name | ARISTOCORT R |
| Generic / active ingredient | TRIAMCINOLONE ACETONIDE : 0.1 % |
| Manufacturer | BAUSCH HEALTH, CANADA INC. |
| Strength | 0.1 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | Prescription |
| ATC code | D07AB09 TRIAMCINOLONE |
| AHFS class | 84:06.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 24-Nov-2020 |
| Original market date | 1997-04-14 00:00:00 |
How is it administered?
Apply in small quantities to the affected areas 3 or 4 times daily.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
null
How is it supplied?
Cream: Aristocort "C" (0.5%), concentrate, 15 g tubes and 50 g tubes; Aristocort "R" (0.1 %), regular, 30 g tubes and 500 g jars. Ointment: Aristocort “R” (0.1%) regular, 30 g tubes.
Contraindications
Untreated bacterial, tubercular, and fungal skin infections; certain viral diseases (herpes simplex, chicken pox, vaccinia); hypersensitivity to any components.
Warnings and precautions
Not for ophthalmic use. Risk of adrenal suppression if used under occlusive dressing or over extensive areas. Prolonged use may produce skin atrophy.
Is TRIAMCINOLONE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by STERIMAX INC (Tier 3 Drug Shortages About & Resources), last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code D07AB09 TRIAMCINOLONE. 4 of 15 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ARISTOCORT C | 0.5 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02194066 |
| ARISTOCORT R | 0.1 % | CREAM | BAUSCH HEALTH, CANADA INC. | MARKETED | DIN 02194058 |
| TRIADERM CRM 0.1% | 0.1 % | CREAM | TARO PHARMACEUTICALS INC | MARKETED | DIN 00716960 |
| ARISTOCORT C CRM 0.5% | 5 MG | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00014648 |
| ARISTOCORT D - CRM TOP 0.025% | .025 % | CREAM | GLADES, DIVISION OF STIEFEL CANADA INC. | CANCELLED POST MARKET | DIN 02194074 |
| ARISTOCORT D CRM 0.025% | .25 MG | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00282448 |
| ARISTOCORT R CRM 0.1% | 1 MG | CREAM | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00014621 |
| ARISTOCORT R ONT 0.1% | .1 % | OINTMENT | LEDERLE CYANAMID CANADA INC. | CANCELLED POST MARKET | DIN 00127914 |
| KENALOG CREAM 0.1% | 1 MG | CREAM | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 01999818 |
| KENALOG OINTMENT 0.1% | 1 MG | OINTMENT | WESTWOOD-SQUIBB, DIVISION OF BRISTOL-MYERS SQUIBB CANADA INC. | CANCELLED POST MARKET | DIN 01999796 |
Who else supplies TRIAMCINOLONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TRIAMCINOLONE appears in 37 registered pack listings across 7 markets, published on 6 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.